SHF Holdings And 3 Other Stocks Under $2 Insiders Are Buying
SHF Holdings And 3 Other Stocks Under $2 Insiders Are Buying
SHF Holdings和其他3只2美元以下的股票業內人士正在買入
The Dow Jones closed higher by over 60 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
道瓊斯指數週四收盤上漲60多點。當內部人士買入或賣出股票時，這表明他們對公司前景的信心或擔憂。對細價股感興趣的投資者和交易者可以將其視爲其整體投資或交易決策中的一個因素。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是近期一些值得注意的細價股內幕交易。欲了解更多，請查看 本辛加的內幕交易 平台。
SHF Holdings
SHF Holdings
- The Trade: SHF Holdings, Inc. (NASDAQ:SHFS) Chief Legal Officer Donald Emmi acquired a total of 66,000 shares an average price of $0.87. To acquire these shares, it cost around $57,420. The company's CEO also bought 20,000 shares of the company.
- What's Happening: On Nov. 14, SHF Hldgs posted a loss for the third quarter.
- What SHF Holdings Does: SHF Holdings Inc is a financial services provider to cannabis-related businesses.
- 交易：SHF Holdings, Inc.（納斯達克股票代碼：SHFS）首席法務官唐納德·艾米 共收購了 66,000 股股票 平均價格爲0.87美元。收購這些股票的成本約爲57,420美元。該公司的首席執行官還購買了該公司的20,000股股票。
- 發生了什麼：11月14日，SHF Hldgs公佈了第三季度的虧損。
- SHF Holdings做什麼：SHF Holdings Inc是大麻相關企業的金融服務提供商。
Quince Therapeutics
昆斯療法
- The Trade: Quince Therapeutics, Inc. (NASDAQ:QNCX) Director David Lamond acquired a total of 57,369 shares at an average price of $1.01. To acquire these shares, it cost around $58,134.
- What's Happening: On Oct. 23, Quince Therapeutics announced the successful completion of its acquisition of EryDel S.p.A.
- What Quince Therapeutics Does: Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases.
- 交易：Quince Therapeutics, Inc.（納斯達克股票代碼：QNCX）董事大衛·拉蒙德 共收購了57,369股股票 平均價格爲1.01美元。收購這些股票的成本約爲58,134美元。
- 發生了什麼：10月23日，Quince Therapeutics宣佈成功完成對Erydel S.p.A的收購。
- Quince Therapeutics的所作所爲：Quince Therapeutics Inc是一家臨床前階段的生物製藥公司，專注於開發針對使人衰弱和罕見疾病的創新精準療法。
Check This Out: 'I Like It Very Much': Jim Cramer Bullish On This Financial Stock Up 75% YTD
看看這個： “我非常喜歡”：吉姆·克萊默看好這隻金融股年初至今上漲75％
Silo Pharma
Silo Pharma
- The Trade: Silo Pharma, Inc. (NASDAQ:SILO) President and CEO Eric Weisblum acquired a total of 1,000 shares at an average price of $1.38. The insider spent around $1,376 to buy those shares.
- What's Happening: On Nov. 21, Silo Pharma entered into exclusive license agreement with Medspray Pharma BV for intranasal technology used in SPC-15 treatment for PTSD.
- What Silo Pharma Does: SILO Pharma Inc is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research.
- 交易：Silo Pharma, Inc.（納斯達克股票代碼：SILO）總裁兼首席執行官埃裏克·韋斯布魯姆 共收購了 1,000 股股份 平均價格爲1.38美元。內幕人士花費了大約1376美元購買了這些股票。
- 發生了什麼：11月21日，Silo Pharma與Medspray Pharma BV就用於創傷後應激障礙 SPC-15 治療的鼻內技術簽訂了獨家許可協議。
- Silo Pharma的所作所爲：SILO Pharma Inc是一家處於發展階段的生物製藥公司，專注於將傳統療法與迷幻藥研究相結合。
Upexi
Upexi
- The Trade: Upexi, Inc. (NASDAQ:UPXI) CEO Allan Marshall acquired a total of 90,001 shares at an average price of $0.94. The insider spent around $84,952 to buy those shares.
- What's Happening: On Nov. 20, Upexi posted a wider-than-expected quarterly loss.
- What Upexi Does: Upexi Inc is an innovator in aggregation, accelerating Amazon and eCommerce businesses by combining consumer data and vertical integration to scale brands in multiple industries, while lowering costs with a growing distribution network.
- 交易：Upexi, Inc.（納斯達克股票代碼：UP****執行官艾倫·馬歇爾 共收購了 90,001 股股票 平均價格爲0.94美元。內幕人士花費了約84,952美元購買了這些股票。
- 發生了什麼：11月20日，Upexi公佈的季度虧損超出預期。
- Upexi的作用：Upexi Inc是聚合領域的創新者，通過結合消費者數據和垂直整合來擴大多個行業的品牌規模，從而加速亞馬遜和電子商務業務的發展，同時通過不斷增長的分銷網絡降低成本。
Don't forget to check out our premarket coverage here
別忘了在這裏查看我們的上市前報道
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。